Giuseppe Valacchi Selected Research

Obesity

2/2018	Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women.
1/2015	Integrated Haematological Profiles of Redox Status, Lipid, and Inflammatory Protein Biomarkers in Benign Obesity and Unhealthy Obesity with Metabolic Syndrome.
2/2014	Effect of combined mulberry leaf and fruit extract on liver and skin cholesterol transporters in high fat diet-induced obese mice.
1/2012	Calorie restriction with a high-fat diet effectively attenuated inflammatory response and oxidative stress-related markers in obese tissues of the high diet fed rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Valacchi Research Topics

Disease

37	Inflammation (Inflammations) 04/2024 - 10/2002
29	Rett Syndrome (Rett's Disorder) 11/2023 - 08/2009
12	Neurodevelopmental Disorders 06/2021 - 08/2009
10	Melanoma (Melanoma, Malignant) 06/2022 - 01/2015
9	Wounds and Injuries (Trauma) 08/2022 - 01/2006
9	Neoplasms (Cancer) 03/2022 - 11/2003
8	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2022 - 06/2010
8	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 06/2016
5	Neuroblastoma 01/2021 - 11/2010
5	Skin Diseases (Skin Disease) 01/2020 - 06/2010
4	Atopic Dermatitis (Atopic Eczema) 04/2022 - 07/2019
4	Acne Vulgaris 04/2022 - 01/2003
4	Obesity 02/2018 - 01/2012
4	Autistic Disorder (Autism) 01/2016 - 01/2013
4	Disease Progression 01/2014 - 07/2011
3	Premature Aging 04/2024 - 07/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 12/2014
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 05/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2019 - 12/2016
3	Cognitive Dysfunction 01/2018 - 06/2016
3	Autism Spectrum Disorder 01/2017 - 01/2013
3	Acute-Phase Reaction 01/2013 - 10/2004
3	Lung Diseases (Lung Disease) 07/2012 - 09/2002
2	Hypertension (High Blood Pressure) 02/2023 - 01/2018
2	COVID-19 10/2022 - 01/2021
2	Vitiligo 04/2022 - 09/2010
2	Infections 05/2021 - 01/2020
2	Atherosclerosis 01/2021 - 12/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2020 - 10/2015
2	Dementia (Dementias) 01/2018 - 06/2016
2	Mixed Dementias 01/2018 - 12/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 07/2012 - 05/2010
2	Breast Neoplasms (Breast Cancer) 01/2012 - 06/2011
1	Contracture 11/2023
1	Neuroinflammatory Diseases 10/2023
1	Myalgia 01/2023
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 08/2022
1	Diabetes Mellitus 08/2022

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 07/2023 - 01/2006
18	Methyl-CpG-Binding Protein 2IBA 06/2021 - 08/2009
11	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2011
11	AntioxidantsIBA 01/2021 - 04/2008
9	CytokinesIBA 01/2023 - 10/2002
9	LipidsIBA 02/2018 - 01/2010
7	InflammasomesIBA 10/2023 - 01/2020
7	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022 - 07/2012
6	SmokeIBA 04/2022 - 05/2010
6	OzoneIBA 01/2022 - 07/2012
6	rottlerinIBA 11/2019 - 06/2009
5	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2014 - 05/2011
4	Particulate MatterIBA 04/2024 - 01/2020
4	Lipoproteins (Lipoprotein)IBA 01/2021 - 01/2017
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 02/2013
4	EnzymesIBA 01/2020 - 11/2010
4	Aryldialkylphosphatase (Paraoxonase)IBA 06/2019 - 12/2016
4	Scavenger Receptors (Scavenger Receptor)IBA 01/2018 - 07/2013
3	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2017
3	Air Pollutants (Pollutants, Air)IBA 01/2021 - 07/2012
3	Amyloid (Amyloid Fibrils)IBA 01/2020 - 06/2016
3	arylesteraseIBA 02/2018 - 12/2016
3	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 10/2017 - 09/2010
3	Messenger RNA (mRNA)IBA 04/2015 - 09/2010
3	high density lipoprotein receptorsIBA 03/2015 - 07/2013
2	Tocopherols (Tocopherol)IBA 04/2024 - 03/2015
2	Anticonvulsants (Antiepileptic Drugs)IBA 11/2023 - 01/2021
2	Peptides (Polypeptides)IBA 02/2023 - 06/2019
2	ChromatinIBA 06/2021 - 01/2013
2	NF-kappa B (NF-kB)IBA 01/2021 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2009
2	ProteomeIBA 01/2021 - 01/2013
2	Bromodeoxyuridine (BrdU)IBA 01/2020 - 09/2015
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 10/2015
2	Cytostatic AgentsIBA 11/2019 - 01/2015
2	Phospholipases A2 (Phospholipase A2)IBA 01/2018 - 01/2017
2	C-Reactive ProteinIBA 01/2018 - 01/2018
2	HDL LipoproteinsIBA 12/2016 - 02/2014
2	ChemokinesIBA 01/2016 - 09/2010
2	Carotenoids (Carotene)IBA 03/2015 - 11/2003
2	CholesterolIBA 02/2014 - 01/2014
2	IronIBA 02/2013 - 11/2010
2	adrenic acid (7,10,13,16-docosatetraenoic acid)IBA 01/2013 - 12/2011
2	Vascular Endothelial Growth FactorsIBA 01/2013 - 01/2011
2	Protein Isoforms (Isoforms)IBA 01/2013 - 09/2010
2	LipopolysaccharidesIBA 03/2007 - 10/2004
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 04/2024
1	ferulic acid (sodium ferulate)IBA 04/2024
1	Vitamin D FDA LinkGeneric 11/2023
1	Diphosphonates (Bisphosphonates)IBA 11/2023
1	CalciumIBA 11/2023
1	Multiprotein ComplexesIBA 10/2023
1	Protein Hydrolysates FDA Link 02/2023
1	Dietary Bioactive PeptidesIBA 02/2023
1	OxylipinsIBA 01/2023
1	astaxanthine (astaxanthin)IBA 01/2023
1	Disinfectants (Biocides)IBA 10/2022
1	Dimethyl FumarateIBA 08/2022
1	Irritants (Vesicants)IBA 08/2022

Therapy/Procedure

5	Therapeutics 01/2020 - 05/2011
2	Radiotherapy 01/2019 - 01/2012